Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
55
Number of overlapping holdings
40.4%
% of XBI's 136 holdings also in SBIO
61.8%
% of SBIO's 89 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 1.2% | 3.6% | 1.2% |
 |
KRYSTAL BIOTECH, INC. | 1.2% | 3.4% | 1.2% |
|
AVIDITY BIOSCIENCES INC | 1.0% | 2.7% | 1.0% |
|
GERON CORP | 0.9% | 1.7% | 0.9% |
|
CRINETICS PHARMACEUTICALS INC | 0.8% | 3.1% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to SBIO
|
NATERA INC | 3.5% |
|
GILEAD SCIENCES INC | 3.0% |
|
INCYTE CORP | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.7% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
EXACT SCIENCES CORP | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
XBI Underweight Relative to SBIO
|
CORCEPT THERAPEUTICS INC | -4.2% |
|
ARCELLX, INC. | -2.5% |
|
ALKERMES PLC | -2.4% |
|
KRYSTAL BIOTECH, INC. | -2.3% |
|
CRINETICS PHARMACEUTICALS INC | -2.2% |
 |
MERUS N.V. | -2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
DENALI THERAPEUTICS INC. | -1.9% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -1.9% |
|
PTC THERAPEUTICS INC | -1.8% |